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In recent years, the simple picture of a viral fusion protein interacting with the cell and/or viral membranes by means of only two localized
segments (i.e. the fusion peptide and the transmembrane domain) has given way to a more complex picture in which multiple regions from
the viral proteins interact with membranes. Indeed, possible roles in membrane binding and/or destabilization have been postulated for the N-
terminal heptad repeats, pre-transmembrane segments, and other internal regions of fusion proteins from distant viruses (such as orthomyxo-,
retro-, paramyxo-, or flaviviruses). This review focuses on the experimental evidence and functional models postulated so far about the role
of these regions in the process of virus-induced membrane fusion.D 2003 Elsevier B.V. All rights reserved.Keywords: Viral entry; Fusion peptide; Protein dissection1. Introduction
Infection of eukaryotic cells by enveloped viruses requires
the fusion of the viral and plasma or endosomal membranes.
Highly specific viral envelope glycoproteins, named ‘‘fusion
proteins’’, catalyze this reaction, thus overcoming its inherent
energy barriers. The current accepted hypothesis postulates
that, at one stage during the fusion process, viral fusion
proteins interact simultaneously with both the viral and cell
membranes, therefore bridging the gap between them [1]. The
interaction between most known fusion proteins and the viral
envelope is mediated by a transmembrane domain that
connects the intraviral (or cytoplasmic) region with the
ectodomain. On the other hand, the interaction with the target
membrane has been thought to involve a hydrophobic stretch
of about 15 residues called ‘‘the fusion peptide’’ [2]. These
segments were initially identified either at the N-terminus, as
in most orthomyxoviruses, paramyxoviruses, and several
retroviruses [2–4], or in the interior of the fusion proteins,
as in Rous Sarcoma virus [5], Vesicular Stomatitis virus [6],
or Ebola virus [7]. It was generally accepted that each viral
fusion protein contains a single fusion peptide and that this0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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the target cell membrane. However, in recent years, new
evidence has surfaced, indicating that, in addition to classical
fusion peptides, other regions from viral fusion proteins
directly interact with membranes, contributing to their merg-
ing. This review focuses on the role of these regions in
membrane fusion.2. The role of the N-terminal heptad repeat
Structural studies of fragments from some fusion proteins
from ortho-, paramyxo-, as well as retroviruses have unrav-
eled a common structural theme shared by the fusion
machines of these unrelated viruses: a heptad repeat region
that follows the N-terminal fusion peptide folds, at an
unknown stage during the fusion process, into a trimeric
helical coiled coil [8] (see Fig. 1). Indeed, formation of the
coiled coil has been postulated to relocate Influenza hemag-
glutinin N-terminal fusion peptide close to the target cell
endosomal membrane [9]. Furthermore, the subsequent
packing of C-terminal helices against the grooves of the
coiled coil would bring the viral and the target membranes
close to one another [10]. Thus, for already a number of
years, N-terminal heptad repeats have been known to play a
crucial role in the structural organization of fusion proteins.
However, recently, a growing number of studies have point-
ed to an additional role for the N-terminal heptad repeat of
Fig. 1. Panel A, schematic organization of the fusion proteins from Influenza, HIV, and Sendai virus. The colored boxes represent the N-terminal fusion
peptide, in pink; the N-terminal heptad repeat, in red; and the C-terminal helix, in blue. The orange vertical strip represents the viral envelope. In Sendai F1, the
additional yellow box represents the putative internal fusion peptide. Note that the residue numbers in the three proteins correspond to the mature polypeptides,
after processing of the signal sequences. Panel B, structural scheme based on the crystal structure of fragments from SV5 F1 and HIV-1 gp41. In both cases,
three N-terminal heptad repeats (in red) form an internal coiled coil against which three C-terminal helices are packed (in blue). The crystal structure of a
fragment of Influenza hemagglutinin in the low pH conformation shows a very similar 3D structure: an internal trimeric coiled coil formed by three N-terminal
heptad repeats and three short helices that surround its C-terminal end.
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the fusion process. These studies are discussed in the
following paragraphs.
2.1. Influenza hemagglutinin
Epand et al. [11] studied the ability of different constructs
corresponding to the ectodomain of Influenza virus hemag-
glutinin to induce membrane fusion of large unilamellar
vesicles. Specifically, they compared the activity of the 20-
residue N-terminal fusion peptide, a 127-residue segment
(FHA2) comprising both the N-terminal fusion peptide, thefollowing coiled coil, the loop that reverses the chain and a
consecutive short helix, and a 95-residue truncated form of
FHA2 lacking the N-terminal fusion peptide (named SHA2).
They found that FHA2 promotes pH-dependent fusion of
liposomes to an extent significantly higher than the N-
terminal fusion peptide alone. Interestingly, this activity
was abolished when the fusion peptide was removed, but
also when residues D109, D112, or E114, all part of the loop
region, were replaced by Cys. Furthermore, although SHA2
did not induce membrane fusion, it promoted the aggregation
of lipid vesicles, proving that regions apart from the fusion
peptide bind to lipid membranes. These results suggest that,
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inducing rapid membrane fusion, the following coiled coil
and loop have an important role in the fusion process [11].
Furthermore, the fact that the lipid mixing activity of a
segment of HA2 showed a pH dependence similar to the
observed for the intact virions suggests that changes in pH
not only affect the interaction between the HA1 and HA2
subunits and the conformation of HA2. The authors sug-
gested that protonation of specific groups in FHA2, presum-
ably in the N-terminal fusion peptide and within an acidic
cluster in the loop region, increased the fusogenic activity of
FHA2. As a result of the protonation, the protein may change
its conformation and/or penetrate deeper into the membrane.
In a subsequent study, Leikina et al. [12] demonstrated that
FHA2 is also capable of inducing cell–cell hemifusion
(fusion of the outer leaflets of the membrane). That FHA2
does not promote full fusion is not surprising: GPI-anchored
constructs of HA lacking the transmembrane and cytoplas-
mic regions also induce hemifusion only [13]. Interestingly,
the FHA2 hemifusion activity required concentrations of
FHA2 similar to those required for HA-mediated cell–cell
fusion. Moreover, FHA2-induced hemifusion was reversibly
blocked by lysophosphatidylcholine and low temperature,
factors that have equivalent effects on HA fusion activity.
Thus, the authors hypothesized that both HA-induced full
fusion and FHA2-induced hemifusion might share similar
mechanisms and that, considering that FHA2 is in the low-
pH stable conformation, hemifusion requires only part of the
energy released in the low pH-induced conformational
change of HA [12].
2.2. Sendai F protein
Infection by paramyxoviruses, a family that includes
severe human respiratory tract pathogens, results in the
formation of large multinucleated cells [14]. In paramyx-
oviruses, both virus–cell as well as cell–cell fusion are
mediated by the F protein. F is synthesized as an inactive
precursor that, after protease activation, is formed by two
disulfide-linked subunits, F1 and F2 [15] (see Fig. 1).
Crystallographic studies of fragments corresponding to the
SV5 F protein N-terminal and C-terminal heptad repeats
have shown that, as with other fusion proteins, three N-
terminal heptad repeats form an internal coiled coil against
which three C-terminal helices are packed [16]. This con-
formation is thought to form late during the fusion process.
In addition to their structural role, heptad repeats from the F
protein of Sendai virus, another member of the paramyx-
oviridae family, were shown to have high affinity toward
phospholipid membranes [17], suggesting a possible in-
volvement in the actual fusion event. In order to further
understand this possible role, Ghosh and Shai [18] com-
pared the ability to induce fusion of large unilamellar
vesicles of constructs of different lengths corresponding to
segments from the F protein. Specifically, they compared
the fusogenic activity of a 33-residue segment that includesthe N-terminal fusion peptide, a 70-residue segment elon-
gated to include also the N-terminal heptad repeat, and two
mutants, one with a mutation in the region of the N-terminal
fusion peptide (G119K) and the other within the heptad
repeat (I154K). These mutations had been shown to drasti-
cally reduce the fusogenic ability of the homologous fusion
protein of Newcastle disease virus. Ghosh and Shai [18]
found that only the 70-residue wild-type peptide was able to
induce membrane fusion of PC/PG large unilamellar
vesicles. The G119K mutation could directly affect the
proper interaction between the N-terminal fusion peptide
and the membrane. On the other hand, the I154K mutation
is far away from the fusion peptide and could only affect it
in an indirect way, presumably by altering the required
structure and/or oligomerization of the heptad repeat. Thus,
they postulated that the heptad repeat assists the N-terminal
fusion peptide during membrane merging.
2.3. HIV gp41
The N-terminal domain of HIV gp41 contains a f 15-
residue hydrophobic fusion peptide, followed by a seg-
ment of about 15 mostly polar residues and a consecutive
heptad repeat (see Fig. 1). Both NMR and crystallographic
studies have shown that three N-terminal heptad repeats
fold into a trimeric coiled coil surrounded by three C-
terminal helices [8,19,20]. This structure, strikingly similar
to the one described for paramyxovirus F protein, has
been suggested to form at a late stage during the fusion
process.
Protein dissection studies have focused on the role of
gp41 N-terminal domain on membrane fusion. As found
with several fusion peptides, a 16-residue peptide
corresponding to the gp41 N-terminal fusion peptide indu-
ces lipid mixing of PC/PE/Cho (1:1:1) large unilamellar
vesicles [21]. Furthermore, it has been shown that exten-
sion of this peptide to include the following 17 mostly
polar residues significantly enhanced its fusogenic activity.
As many other fusion peptides, the N-terminal 16-residue
peptide decreased the bilayers to hexagonal phase transi-
tion temperature of dipalitoleoylphosphatidylethanolamine
(TH), suggesting its ability to promote negative curvature in
membranes; surprisingly, the longer 33-residue peptide that
includes both the N-terminal fusion peptide as well as the
following polar region, raised the TH. Analysis of the
different segments by means of FTIR and fluorescence
spectroscopy lead to the hypothesis that the first 16
residues of the full-length peptide are inserted into the
membrane, promoting negative curvature, thus facilitating
the formation of a stalk intermediate in membrane fusion
[21]. The 17 consecutive residues lie near the surface of
the membrane, contributing to the correct oligomerization
of the peptide, further enhancing its fusogenic activity [21].
Initial evidence supporting a more direct role for the N-
terminal heptad repeat in membrane fusion came from
protein dissection studies that showed that peptides cor-
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phospholipid bilayers with high affinity [22,23]. Indeed,
elongation of the mentioned 33-residue peptide (that com-
prised the fusion peptide and the consecutive polar region)
to include the full N-terminal heptad repeat resulted in a
70-residue segment with dramatically increased fusogenic
activity [24]. Interestingly, the I62D mutation in the C-
terminal region of the heptad repeat, far away from the N-
terminal fusion peptide and known to render the virus
noninfectious [25], resulted in a significant reduction of the
fusogenicity of the 70-residue peptide. This mutation is
believed to block the ability of the heptad repeat to form a
stable trimeric coiled coil, suggesting that the correct
structure and/or oligomeric state of the full-length peptide
is necessary for its proper activity.Fig. 2. Panel A, schematic representation of HIV gp41 and Foamy gp47, the fusion
terminal fusion peptide, in pink; the N-terminal heptad repeat, in red; and the C-te
The pre-transmembrane regions are located between the C-terminal helices and the
membrane interactions of N-terminal fusion peptides and C-terminal pre-transmem
the bilayer, while their C-termini are further away from the membrane. On the c
membrane (in fact, they may be already part of the transmembrane domain). In the
terminal helix by a blue cylinder, and the transmembrane segment by a light bro3. The role of the ‘‘pre-transmembrane’’ region
The importance of viral fusion proteins transmembrane
and pre-transmembrane segments on the mechanism of viral
entry has been postulated long time ago. In a pioneering
work, Salzwedel et al. [26] showed that replacement of the
transmembrane segment of gp41 by a by a glycosyl-phos-
phatidylinositol anchor (GPI) resulted in a loss of syncytium
forming capacity, although the protein was still attached to
the membrane. Along this line, it was demonstrated that
GPI-anchored Influenza hemagglutinin promotes cell–cell
hemifusion [13]. This suggested a role for hemagglutinin
transmembrane domain in the formation of a stable fusion
pore and in its expansion. Furthermore, mutational studies
with the full-length HIV-1 gp41 showed that the pre-proteins from two different retroviruses. The colored boxes represent the N-
rminal helix, in blue. The orange vertical strip represents the viral envelope.
viral envelopes. Panel B, cartoon highlighting the opposite topology in the
brane regions. The N-terminal fusion peptides have their N-termini closer to
ontrary, the pre-transmembrane regions have their C-termini closer to the
scheme, the N-terminal heptad repeat is symbolized by a red cylinder, the C-
wn cylinder.
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for complete fusion [27,28]. These studies highlighted the
importance of the C-terminal regions of fusion proteins
ectodomains in the process of membrane merging. More
recently, new reports pointed to a direct role in membrane
destabilization.
3.1. HIV
Suarez et al. [29] first suggested a direct involvement
of the pre-transmembrane region of a fusion protein in the
actual membrane destabilization process. They observed
that a Trp-rich segment located at the C-terminus of HIV-
1 gp41 ectodomain, displayed a high tendency to partition
into the membrane interface as revealed by the interfacial
hydrophobicity scale developed by Wimley and White
[30]. They showed that synthetic peptides correspondingFig. 3. Panel A, on top, the pre-transmembrane sequence of Human Foamy Vir
sequence (Retro-HFV-Env) are shown; at the bottom, the alignment between Re
Identical positions are marked in yellow, similar positions in blue. A Lys in the F
marked in red. Panel B, alignment between the pre-transmembrane regions of five F
HFV; and simian, SFV) and four Flavivirus Envelope Protein E (Tick-borne Encep
Nile virus, WN). As before, identical positions are marked in yellow and similar p
gp41 N-terminal fusion peptide is underlined. At the bottom, the multiple alignmto a 20-residue segment that immediately precedes the
gp41 transmembrane domain, and includes the Trp-rich
region (see Fig. 2A), induces destabilization of PC/PE/
Cho (1:1:1) liposomes (i.e. permeabilization and lipid
mixing). Furthermore, mutations within this region that
render gp41 nonfunctional resulted in inactive peptides.
The authors concluded that the membrane-perturbing ac-
tivity of the gp41 pre-transmembrane region mirrors that
of the polar segment that follows the N-terminal fusion
peptide [29]. Indeed, the structural organization of the N-
terminus and C-terminus of gp41 ectodomain share two
elements: a hydrophobic segment that inserts into the
membrane (the fusion peptide at the N-terminus and the
transmembrane domain at the C-terminus), followed by (in
the case of the N-terminus) or preceded by (in the case of
the C-terminus) more polar helical regions that assist in
the fusion process.us Env (HFV-Env, as a representative of all Foamy viruses) and its retro-
tro-HFV-Env and the N-terminal fusion peptide of HIV-1 gp41 is shown.
oamy protein and the N-terminal positive charged from the HIV protein are
oamy virus fusion proteins (bovine, BFV; equine, EFV; feline, FFV; human,
halitis virus, TBE; Powasan virus, POW; Yellow Fever virus, YF; and West
ositions in blue. The region in the Foamy proteins analogous to the HIV-1
ent is shown in a Logo representation.
Fig. 4. Panel A, schematic representation of Sendai F1 protein indicating
the region that corresponds to the putative internal fusion peptide. As
observed, this segment is highly similar to the N-terminal fusion peptides of
HIV-1 gp41 (a retroviral protein) and Respiratory Syncytial virus F1 (a
paramyxoviral protein). Panel B, left, model based on studies done with
peptides from Sendai F1; right, model based on the crystal structure of
Newcastle disease virus. The coiled coils formed by the N-terminal heptad
repeats are shown in red and the putative internal fusion peptides in yellow.
S.G. Peisajovich, Y. Shai / Biochimica et Biophysica Acta 1614 (2003) 122–129 1273.2. Foamy and flaviviruses
Gp47, the protein responsible for Foamy virus-induced
membrane fusion, contains a putative N-terminal fusion
peptide and a putative C-terminal transmembrane domain
[31], the latter unusually long for retroviral fusion proteins
(see Fig. 2A). This prompted Epand and Epand [32] to
investigate a possible role in membrane destabilization for
the most external portion of the putative transmembrane
domain. They found that, as with other viral fusogenic
segments, a synthetic peptide corresponding to the pre-
transmembrane domain region induces fusion of model
PC/PE/Cho (1:1:1) membranes [32]. The membrane-desta-
bilizing activity of the pre-transmembrane segment from
Foamy virus is similar to that reported for the equivalent
region from HIV-1 gp41 and suggests that other retroviral
fusion proteins might destabilize both the target membrane
(with the N-terminal fusion peptide) and the viral membrane
(with the pre-transmembrane region) during the fusion
process.
Retroviral N-terminal fusion peptides have common
features at the level of their amino acid sequences [4]. They
have a high content of Ala, Gly, and Phe and, sometimes,
tandem repeats of the tripeptide FLG are present [4]. The
similarities observed between the membrane destabilizing
activities of N-terminal and pre-transmembrane segments
from different retroviruses suggest that these regions might
also have commonalities in their primary sequences. How-
ever, sequence comparison between these two regions must
consider that the interactions between target cell bilayers
and the N-termini of viral fusion proteins and between the
viral bilayer and the pre-transmembrane regions have ‘‘op-
posite’’ topologies [33] (see Fig. 2B). The N-terminal fusion
peptides have their N-termini closer to the bilayer, while
their C-termini are further away from the membrane. On the
contrary, the pre-transmembrane regions have their C-ter-
mini closer to the membrane (in fact they may be already
part of the transmembrane domain). Indeed, classical se-
quence alignments between N-terminal fusion peptides and
the Foamy virus pre-transmembrane region did not yield
significant similarities [33]. However, alignments between
the ‘‘reversed’’ Foamy virus pre-transmembrane sequence
(writing it from C-t to N-t, instead of from N-t to C-t, thus
correcting for the opposite topology of N-terminal fusion
peptides and C-terminal pre-transmembrane regions) and N-
terminal fusion peptides from retroviruses lead to the
identification of highly similar regions belonging to the
Foamy pre-transmembrane region and the N-terminal fusion
peptide of HIV gp41 [33] (see Fig. 3A). Strikingly, the
tripeptide FIG in the retro-Foamy sequence aligned with the
HIV-1 FLG tripeptide and about 50% of the matches
corresponded to Ala or Gly, residues known to be important
for the activity of fusion peptides. Furthermore, sequence
analysis studies detected a region in the C-terminal end of
the ectodomain of the Envelope Protein E from Flaviviruses,
particularly among members of the Tick-Borne Encephalitisvirus group, highly similar to that of Foamy viruses [33]
(see Fig. 3B). As in Foamy viruses, this analogous region
comprises the pre-transmembrane as well as part of a
putative transmembrane segment [34]. This strongly sug-
gests that the pre-transmembrane region of the Flavivirus
Envelope Protein E might play a role in membrane desta-
bilization during the fusion process. The sequence similarity
between pre-transmembrane regions of FV-Env and Flavi-
virus Protein E is unexpected, since the structure of the latter
is very different from all known retroviral fusion proteins
[34].4. Paramyxovirus internal fusion peptide
The ectodomain of the paramyxovirus F protein is
composed of about 500 residues. As mentioned before,
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form an N-terminal fusion peptide that is followed by a
heptad repeat (see Fig. 1). It has been postulated that,
consecutive to the heptad repeat, the F1 protein from
Sendai virus contains a second fusogenic domain, highly
homologous to known N-terminal fusion peptides [35] (see
Fig. 4A). Experimental evidence suggesting a role for this
region in paramyxovirus-induced membrane fusion came
from protein dissection studies that showed that peptides
encompassing this region could induce fusion of large
unilamellar vesicles [35,36]. Moreover, some of these
peptides inhibited Sendai virus infection of red blood cells,
presumably blocking conformational changes in the F
protein [37]. When the existence of a second internal
fusion peptide in the F1 protein was postulated, the
structure of the pre-fusion conformation of the F protein
was not known. Thus, a structural model based on func-
tional studies done with different peptides was postulated
[35,37]. The model was based on the following informa-
tion: (i) The peptides corresponding to residues 208–229
or 201–229 of Sendai virus F protein (see Fig. 4A) bind to
the surface of the membrane, adopting a-helical structure.
(ii) The peptide corresponding to residues 201–229 oligo-
merizes in aqueous solution, whereas removal or mutation
of its N-terminal residues results in the loss of its oligo-
merization ability [37]. Based on these results, and con-
sidering that the coiled coil formed by the N-terminal
heptad repeats is believed to be perpendicular to the
membrane during the onset of viral entry, it was hypoth-
esized that the internal fusion peptide could form a helix
perpendicular to the coiled coil [37]. The different abilities
of the peptides to homo-oligomerize indicated that the N-
terminal region of each internal fusion peptide could be
close to the trimeric coiled coil, while the C-terminal ends
could extend radially, away from the central axis (see Fig.
4B). This hypothetical model required that upon binding of
the virion to cell receptors, the consequently induced
conformational change in F2/F1 results in the exposure
of the internal fusion peptide region and its subsequent
interaction with the target membrane [38].
The recent determination of the crystal structure of the
pre-fusion conformation of the Newcastle Disease virus
(NDV, a paramyxovirus) F protein [39] validated this
model: the internal fusogenic region is part of an a-helix
that extends radially from the internal coiled coil and is
almost perpendicular to it (see Fig. 4B). In the crystal
structure, a ‘‘head’’ formed by segments from the F1 and
the F2 subunits hides the internal fusogenic region. There-
fore, for this region to be exposed during an intermediate
stage in the fusion process, a conformational change that
moves the head away is required. Indeed, there is ample
evidence supporting the opening of the head region [38–
41].
It is interesting to note that the location of the paramyxo-
virus putative internal fusogenic region, on top of the N-
terminal trimeric central coiled coil, is equivalent to thelocation of the Influenza hemagglutinin loop that connects
the N-terminal coiled coil with the short helix that follows
and also to the HIV/SIV gp41 loop that connects the N-
terminal coiled coil with the C-terminal helices. Indeed, as
described here for the paramyxovirus putative internal
fusion peptide, both the Influenza hemagglutinin and HIV/
SIV gp41 loops have been postulated to bind to phospho-
lipid membranes [11,42,43].5. Concluding remarks
In recent years, the simple picture of a viral fusion
protein interacting with the cell and/or viral membranes
by means of only two localized segments (i.e. the fusion
peptide and the transmembrane domain) has given way to a
more complex picture in which multiple regions from the
viral proteins interact with membranes. Although still large-
ly hypothetical, the roles played by these regions could vary,
from simply assisting N-terminal fusion peptides to adopt
their correct structure and/or oligomeric state, to promote
membrane apposition, to directly destabilize the viral and/or
target membranes leading to fusion. Future experiments
shall shed light into the precise function each region has
in the context of the intact virions.References
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